Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner
October 9, 2025
Halia Therapeutics has been named one of the Top 10 Longevity Breakthrough Award Winners for 2025. This recognition reflects Halia’s mission to redefine human potential by addressing the root cause of chronic diseases: inflammation. Congratulations Halia!
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
